Roche Earnings: And the Numbers Will Be….
Make a commentBy Ed Silverman // February 6th, 2007 // 5:05 pm
The big drugmaker is set to report its 2006 results tomorrow and the results are likely to be upbeat, certainly when compared with some of its rivals.
“We like Roche’s fundamentals and mix of products and earnings outlook, especially for the next two years,” writes Tim Anderson of Prudential Equity, in an investor note this week.
Roche previously provided Wall Street with some guidance, although as Anderson points out, the company is often vague. Nonetheless, he looks for pharma sales rising 21 percent and diagnostic sales increasing nearly 5 percent. As for core earnings, he models 28 percent growth. [tags]Roche[/tags]